M.D.C. (MDC) Q2 2024 earnings summary

Executive summary

• Net income for Q2 2024 was $25.1M, down 73% year-over-year, mainly due to higher SG&A and transaction costs from the Sekisui House merger.

• Net income for the first half of 2024 was $121.0M, down 31% year-over-year.

• Homebuilding pretax income fell 77% in Q2 and 29% for the first half, while financial services pretax income rose 8% in Q2 and 3% for the first half.

• The company was acquired by Sekisui House in April 2024, resulting in delisting from the NYSE and transition to private ownership.

Financial highlights

• Q2 2024 home sale revenues increased 28% year-over-year to $1.41B; gross margin from home sales rose 170 bps to 18.1%.

• SG&A expenses as a percentage of home sale revenues increased 570 bps to 15.4% in Q2 2024, driven by merger-related equity vesting and executive bonuses.

• Transaction costs related to the merger were $27.6M in Q2 and $38.3M for the first half.

• Inventory impairments were $4.6M in Q2 2024, down from $13.5M in Q2 2023.

• Cash and cash equivalents plus marketable securities totaled $1.10B at quarter end; total liquidity was $2.19B.

Outlook and guidance

• Management remains focused on maximizing risk-adjusted returns, minimizing leverage, and maintaining a strong balance sheet.

• The company believes it is well-positioned to navigate market volatility due to strong liquidity and a seasoned leadership team.

• No senior note maturities until 2030; total lot supply is considered sufficient for operating needs.